Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. - Wikidata - awgldk - TriplyDB

Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34.

Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34.

http://www.wikidata.org/entity/Q42161087

about

Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application Murine and human myogenic cells identified by elevated aldehyde dehydrogenase activity: implications for muscle regeneration and repair Advances in complex multiparameter flow cytometry technology: Applications in stem cell research.Extended flow cytometry characterization of normal bone marrow progenitor cells by simultaneous detection of aldehyde dehydrogenase and early hematopoietic antigens: implication for erythroid differentiation studies.Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities Human milk protein production in xenografts of genetically engineered bovine mammary epithelial stem cells.ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.Aging is not associated with bone marrow-resident progenitor cell depletion Timing of peripheral blood stem cell yield: comparison of alternative methods with the classic method for CD34+ cell determination Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function.Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation.Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity.Isolation of human umbilical cord blood aldehyde dehydrogenase-expressing progenitor cells that modulate vascular regenerative functions in vitro and in vivo.Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival Biology and flow cytometry of proangiogenic hematopoietic progenitors cells.Aldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis.Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials.Investigational agents for sickle cell disease.Development and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assay Pharmacological manipulation of the RAR/RXR signaling pathway maintains the repopulating capacity of hematopoietic stem cells in culture.Liver stem cells and hepatocellular carcinoma.Targeting aldehyde dehydrogenase: a potential approach for cell labeling.Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity.Quality of cord blood cryopreserved for up to 5 years.The role of human aldehyde dehydrogenase in normal and cancer stem cells.Concise review: aldehyde dehydrogenase bright stem and progenitor cell populations from normal tissues: characteristics, activities, and emerging uses in regenerative medicine.Is it time to revisit our current hematopoietic progenitor cell quantification methods in the clinic?Aldehyde dehydrogenases in acute myeloid leukemia.Purification of hematopoietic stem cells from bone marrow.Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation.The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance Aldehyde dehydrogenase activity as a functional marker for lung cancer.An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.Epigenetic reprogramming induces the expansion of cord blood stem cells.Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1.Isolation of hematopoietic stem cells and the effect of CD38 expression during the early erythroid progenitor cell development process Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27.Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.

P2860

Q24676524-DF1033DC-FC7C-4D8B-9721-A6DBD708CD95 Q28265682-D52BF922-3201-4BC0-AEBD-08D87314AFF4 Q28741359-C9A792F4-6972-42D2-A26C-5840C27A914F Q30479710-1FC7FEF5-8EE4-479A-9DC8-421AFCFFB972 Q33338664-531F7610-F2BD-4E72-9C12-01C3D6BF0C6E Q33489590-6AAF2CF2-E845-47C1-BE74-3F8BC9C3DF2E Q33713162-B136CE57-3423-4C2D-B72D-BDCD70F95659 Q33728160-005E72FF-624E-4A8C-98B1-AB6ED2616DDF Q33939548-8C488891-1F85-4797-B57B-EECE22CF857E Q34171737-1499F2F7-6517-4B35-B6C1-7921F4118375 Q34234005-A78BF489-6D49-4702-8E09-1A5E6F19521F Q34295969-229CE64B-B6D3-486A-B7A6-8E4284B6FD9B Q34541687-87C0E867-861A-41AC-9C64-F86A54C48FEB Q34609741-3BA0E375-ED36-40DA-82E8-1E7DE78B849A Q34714056-1C8B4615-9F7A-405F-BF41-111AE813AD5E Q35022205-4226A636-7A92-42F6-8577-F06420E2D1BB Q35168107-4200BD8E-78E6-4906-851D-80A13DD60CF2 Q35758016-737DBADB-DC8C-444D-9A85-3F30C241FE7E Q36453570-B36CD83C-9963-49AF-B2A0-91E84E7B2FDD Q36543049-DBC94B64-FF02-44BF-96AB-B038F1883945 Q36897147-B499BA40-4A0A-4227-9FE3-E10035F43925 Q37106888-1432D5F1-F84A-4E5B-92A5-489560E8B3DD Q37358938-B29E2A17-2E5F-4024-BB9A-D3247DC70643 Q37407168-0D00272E-BE31-493E-A465-7995384888CC Q37539087-AB4C659D-1494-4781-8701-DD3641C289E1 Q37683269-614DF712-6C14-44D6-A030-44A63168116C Q37811959-099BCB2E-8C6A-4046-A3D6-DDBDBED5BD68 Q37838867-3C02C983-F911-4989-A0A2-1534227A6962 Q37964485-434EDE96-01E7-4357-A0D9-B1552051517B Q38196948-950361F1-8975-4EB9-94FA-6BC5ADFB0F90 Q38726919-D3710ECE-3BDA-4FE7-9A91-0856A155F62F Q38824383-2095689E-3CC0-4EB7-AC1D-4BCF1B4280F1 Q39444027-536FD8FA-3AE2-42AE-95F3-5EB3434E8237 Q39925109-7A082C91-2667-444D-8663-1D8DA8959CB4 Q39940144-49A9E91B-7AD1-40C0-9AEE-6E94EEB552A0 Q40064521-46A3449E-EA6C-43F1-910F-735487B3B3E6 Q41937047-250475B4-DACA-4030-87DF-9C2B3D308258 Q42128554-9AE5DFAA-83AB-4E30-8DC3-59DC38BFEC93 Q42137660-6FFE1B93-19CA-4EC0-9560-6681E2BA974A Q42713409-A16BD818-ED49-4E61-A478-A9761035A0B9

P2860

Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34.

http://www.wikidata.org/entity/Q42161087

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Distinct hematopoietic progeni ...... dehyde dehydrogenase and CD34.

@en

Distinct hematopoietic progeni ...... dehyde dehydrogenase and CD34.

@nl

type

label

Distinct hematopoietic progeni ...... dehyde dehydrogenase and CD34.

@en

Distinct hematopoietic progeni ...... dehyde dehydrogenase and CD34.

@nl

prefLabel

Distinct hematopoietic progeni ...... dehyde dehydrogenase and CD34.

@en

Distinct hematopoietic progeni ...... dehyde dehydrogenase and CD34.

@nl

P1433

Q42161087-492079D9-6080-435F-996C-F4078D218BA8

P1476

Q42161087-AF529F36-0805-4E3A-815A-5EF643294808

P2093

Q42161087-0FE167D6-457A-4A96-9FB1-F0C90ED45AE7

Q42161087-27AD561A-FC98-40BC-B3A7-BFED56692532

Q42161087-7F53C2DC-A5B6-42BB-925D-089009F7A699

Q42161087-84BD463A-46ED-4226-93C8-ED97E17FC482

Q42161087-9B61E56D-D1BC-4E5E-B532-A07C29D08686

Q42161087-AE5D5C5A-4EA3-47C9-9F9D-DDFDEAB49C43

Q42161087-B2668A23-9409-47AB-9B16-A1C1503ACE11

Q42161087-D48CB8B9-607C-4801-8102-0E066FA59FA1

P2860

Q42161087-1421A284-1DC1-4D64-B940-C3676181E82D

Q42161087-1964A6BE-E36F-46E2-9041-2EE5F59745CD

Q42161087-2CFC60CA-DE54-44E8-AA0A-283201A513AA

Q42161087-3904DA77-9C0B-490B-86C9-2DF5C3E22803

Q42161087-4FDB653B-70B3-471E-839F-EEAE9442E36F

Q42161087-5C8623CF-2F7A-44F2-A1DB-5FB787B2BEAC

Q42161087-616B1249-EACF-4965-9A4C-FFB7038BBB35

Q42161087-6F66BA3E-06C4-46B7-9F9F-AB0189B1401F

Q42161087-7F71034D-668F-41B7-A466-7783270417A5

Q42161087-871EC51B-D2D8-4681-8604-B1EA5647C348

P304

Q42161087-31E33C12-1A9F-4262-91C0-9A8FE7DACAD0

P31

Q42161087-0B3A0C66-B01D-4357-A979-0A6DE3988A8F

P356

Q42161087-8F31A2B3-9827-4D9B-844D-3A58DC78B8AD

P407

Q42161087-D9D792EB-7F42-42A6-AEA6-FF424DBDB397

P433

Q42161087-5D5BF000-8EE8-48DD-A848-2F77986B037C

P478

Q42161087-EF1A8864-3124-4917-948E-36928BAE4F50

P50

Q42161087-D1DA0550-67CD-494F-870F-3CF5F01F30AD

P577

Q42161087-96EE6038-CE87-4754-84EE-D9EE7099FBC0

P5875

Q42161087-5C2C7D59-303D-430C-9E1F-7B3B7E593AA4

P698

Q42161087-0603234B-76A9-4148-9CC2-3F937A3F31EB

P932

Q42161087-2C0D7DC0-C20F-48B7-9A48-93795041CBCA

P356

BLOOD-2004-09-3652

P1433

P1476

Distinct hematopoietic progeni ...... dehyde dehydrogenase and CD34.

@en

P2093

Clayton A Smith

http://www.w3.org/2001/XMLSchema#string

Donna Niedzwiecki

http://www.w3.org/2001/XMLSchema#string

Henry E Rice

http://www.w3.org/2001/XMLSchema#string

Kristine M Safford

http://www.w3.org/2001/XMLSchema#string

Nelson J Chao

http://www.w3.org/2001/XMLSchema#string

O Michael Colvin

http://www.w3.org/2001/XMLSchema#string

Patrick D Green

http://www.w3.org/2001/XMLSchema#string

Robert W Storms

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy

A clonogenic common myeloid progenitor that gives rise to all myeloid lineages

Hoechst dye efflux reveals a novel CD7(+)CD34(-) lymphoid progenitor in human umbilical cord blood.

Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity.

In search of "stemness".

Clonal, in vivo behavior of the totipotent hematopoietic stem cell.

Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.

The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro.

Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells.

In vitro maintenance of highly purified, transplantable hematopoietic stem cells.

P304

95-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2004-09-3652

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Christopher R. Cogle

P577

2005-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7944721

http://www.w3.org/2001/XMLSchema#string

P698

15790790

http://www.w3.org/2001/XMLSchema#string

P932

1895136

http://www.w3.org/2001/XMLSchema#string